Created in 2010 (Sweden), Cormorant Pharmaceuticals own 496 sister brands and 17477 competing brands. The Cormorant Pharmaceuticals brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. Cormorant Pharmaceuticals belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(Cormorant Pharmaceuticals)
over 5 years*
USD 51.82